Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.
- DOI
- 10.1016/s1470-2045(26)00255-x
- Published
- 2026 Sep
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00255-x,
title = {Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.},
author = {Gunster JLB and Tramm T and Machiels M and Demaria S and Formenti SC and de Caluwe A and Duane F and Klein J and Sur D and Somaiah N and Rakovitch E and Jerzak KJ and Lu FI and Hiley CT and Brackstone M and Ehinger A and Maley SK and Acs B and Zerdes I and Ozcan D and Khramtsov A and Salido E and Papathomas TG and Sharma P and Stecklein S and Khramtsova G and Horvath Z and Markov D and Hardas A and do Prado Moura JF and Ramirez A and Woodward WA and Sivapiragasam A and Denkert C and Michiels S and Loi S and Poortmans P and Mutter RW and Salgado R and Tran WT and International Immuno-Oncology Biomarker Working Group},
year = {2026},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(26)00255-x},
url = {https://doi.org/10.1016/s1470-2045(26)00255-x}
}RIS
TY - JOUR TI - Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group. AU - Gunster JLB AU - Tramm T AU - Machiels M AU - Demaria S AU - Formenti SC AU - de Caluwe A AU - Duane F AU - Klein J AU - Sur D AU - Somaiah N AU - Rakovitch E AU - Jerzak KJ AU - Lu FI AU - Hiley CT AU - Brackstone M AU - Ehinger A AU - Maley SK AU - Acs B AU - Zerdes I AU - Ozcan D AU - Khramtsov A AU - Salido E AU - Papathomas TG AU - Sharma P AU - Stecklein S AU - Khramtsova G AU - Horvath Z AU - Markov D AU - Hardas A AU - do Prado Moura JF AU - Ramirez A AU - Woodward WA AU - Sivapiragasam A AU - Denkert C AU - Michiels S AU - Loi S AU - Poortmans P AU - Mutter RW AU - Salgado R AU - Tran WT AU - International Immuno-Oncology Biomarker Working Group PY - 2026 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(26)00255-x UR - https://doi.org/10.1016/s1470-2045(26)00255-x ER -
APA
JLB, G., T, T., M, M., S, D., SC, F., A, D. C., F, D., J, K., D, S., N, S., E, R., KJ, J., FI, L., CT, H., M, B., A, E., SK, M., B, A., I, Z., D, O., A, K., E, S., TG, P., P, S., S, S., G, K., Z, H., D, M., A, H., JF, D. P. M., A, R., WA, W., A, S., C, D., S, M., S, L., P, P., RW, M., R, S., WT, T., & Group, I. I. B. W. (2026). Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00255-x
Source records
- pubmed · retrieved 2026-09-26T15:44:33.076Z